AMPH FY 2013 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$863M

FY 2013 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$230M+12.4% YoY

Gross Profit

$87M37.9% margin

Operating Income

$17M7.6% margin

Net Income

$12M5.2% margin

EPS (Diluted)

$1.48

Cash Flow

Operating Cash Flow

$31M

Free Cash Flow

$13M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$339M

Total Liabilities

$87M

Stockholders' Equity

$252M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$230M	$204M	+12.4%
Gross Profit	$87M	$90M	-3.7%
Operating Income	$17M	$25M	-31.1%
Net Income	$12M	$18M	-34.4%